Capital Options Slims for Cannabis Businesses, But Money Still Accessible
Cannabis companies looking for a cash injection will probably have a more challenging time in the coming months.
Cannabis companies looking for a cash injection will probably have a more challenging time in the coming months.
Cash-strapped Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) continued to refocus its operations through the third quarter ended Sept..
The modern marijuana industry is headed toward massive consolidation that will eventually feature just a handful of companies atop a global supply chain, predicted Curaleaf Executive Chairman Boris Jordan during an appearance.
High Times and the company it bought Moxie Holdings, have much in common. Both companies failed to go public as.
By now, everybody in the psychedelics industry knows the story of lysergic acid diethylamide (LSD):
The legalization of hemp under the 2018 Farm Bill has opened the doors for researchers to study CBD and its anti-inflammatory properties. There are a growing number of studies that support.
At least seven localities in Colorado and Rhode Island voted down recreational marijuana sales measures on Election Day this week, another.
CBD is not only popular but also a holistic choice for people struggling with pain, inflammation, and sleep problems. But many first-time users wonder why CBD is so expensive. Some people.
Florida-based multistate operator Trulieve (CSE: TRUL) (OTCQX: TCNNF) announced a $115 million loss for the third quarter this year, but the company made clear.
We just saw the headlines, and maybe you saw it too: “California Fully Legalizes Medical Cannabis for Pets!” Please excuse the incredibly clickbait title here. Pets cannot consume your traditional medical.